Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.59 |
| ▸ | GLA | P06280 | 1/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.54 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.54 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.52 |
| ▸ | WDR5 | P61964 | 1/20 | 0.50 |
| ▸ | METAP2 | P50579 | 1/20 | 0.49 |
| ▸ | METAP1 | P53582 | 1/20 | 0.49 |
| ▸ | PDE10A | Q9Y233 | 2/20 | 0.49 |
| ▸ | LDHA | P00338 | 1/20 | 0.48 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6917576 | 0.98 | CYP1A2 (0.57) | HPGDALDH1A1CYP1A2KDM4EMEN1 | |
| SCHEMBL6917579 | 0.98 | CYP1A2 (0.57) | HPGDALDH1A1CYP1A2KDM4EMEN1 | |
| SCHEMBL6907789 | 0.98 | CYP1A2 (0.57) | HPGDALDH1A1CYP1A2KDM4EMEN1 | |
| SCHEMBL6907791 | 0.98 | CYP1A2 (0.57) | HPGDALDH1A1CYP1A2KDM4EMEN1 | |
| SCHEMBL6916502 | 0.98 | CYP1A2 (0.57) | HPGDALDH1A1CYP1A2KDM4EMEN1 | |
| Ammonia Solution, Strong SCHEMBL7720483 | 0.98 | CYP1A2 (0.57) | HPGDALDH1A1CYP1A2KDM4EMEN1 | |
| SCHEMBL6915993 | 0.98 | CYP1A2 (0.57) | HPGDALDH1A1CYP1A2KDM4EMEN1 | |
| SCHEMBL6917031 | 0.98 | CYP1A2 (0.57) | HPGDALDH1A1CYP1A2KDM4EMEN1 | |
| SCHEMBL6916761 | 0.98 | CYP1A2 (0.57) | HPGDALDH1A1CYP1A2KDM4EMEN1 | |
| SCHEMBL6915698 | 0.98 | CYP1A2 (0.57) | HPGDALDH1A1CYP1A2KDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1232 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115612095-B | High-temperature-resistant semi-aromatic copolyamide, preparation method thereof, composition and molded product | 上海凯赛生物技术股份有限公司 | 2024-11-26 | — | — | CN | claimed |
| WO-2024106220-A1 | RESIN FOR ACTIVE ENERGY RAY CURABLE INK, COMPOSITION FOR ACTIVE ENERGY RAY CURABLE INK, INK COMPOSITION, AND PRINTED MATERIAL | ＤＩＣグラフィックス株式会社 | 2024-05-23 | — | — | WO | claimed |
| US-20240150523-A1 | HIGH TEMPERATURE RESISTANT SEMI-AROMATIC COPOLYIMIDE, PREPARATION METHOD, COMPOSITIONS, AND MOLDED PRODUCT | CATHAY BIOTECH INC. (CN) | 2024-05-09 | — | — | US | claimed |
| EP-4357391-A1 | HIGH-TEMPERATURE-RESISTANT SEMI-AROMATIC COPOLYIMIDE AND PREPARATION METHOD THEREFOR, COMPOSITION, AND MOLDED ARTICLE | Cathay Biotech Inc. (CN) | 2024-04-24 | — | — | EP | claimed |
| CN-117659389-A | Semi-aromatic polyamide with low water absorption and preparation method thereof | 山东广垠新材料有限公司 | 2024-03-08 | — | — | CN | claimed |
| CN-117416983-A | Naphthoxyhc acid and/or its derivative acid radical intercalation hydrotalcite-like compound and its preparation method | 中国科学院青海盐湖研究所 | 2024-01-19 | — | — | CN | claimed |
| CN-116836081-A | Ether epoxy toughening agent and preparation method and application thereof | 中国林业科学研究院林产化学工业研究所 | 2023-10-03 | — | — | CN | claimed |
| CN-113866322-B | Method for detecting aforana intermediate by reversed-phase high performance liquid chromatography | 丽珠集团新北江制药股份有限公司 | 2023-05-23 | — | — | CN | claimed |
| CN-114113388-B | Method for detecting related substances in 4-oxime methyl-1-naphthoic acid | 丽珠集团新北江制药股份有限公司 | 2023-05-23 | — | — | CN | claimed |
| WO-2023284285-A1 | HIGH-TEMPERATURE-RESISTANT SEMI-AROMATIC COPOLYIMIDE AND PREPARATION METHOD THEREFOR, COMPOSITION, AND MOLDED ARTICLE | 上海凯赛生物技术股份有限公司 | 2023-01-19 | — | — | WO | claimed |
| WO-2006097460-A1 | HYDROXAMATES AS HISTONE DEACETYLASE INHIBITORS AND PHARMACEUTICAL FORMULATIONS CONTAINING THEM | MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. (LU) | 2006-09-21 | — | — | WO | claimed |
| US-20060178414-A1 | Substituted biaryl amides as C5a receptor modulators | NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) | 2006-08-10 | — | — | US | claimed |
| EP-1487796-A4 | SUBSTITUTED BIARYL AMIDES AS C5A RECEPTOR MODULATORS | NEUROGEN CORP (US) | 2005-11-16 | — | — | EP | claimed |
| US-6943267-B1 | compounds structurally resemble the substrates of the enzymes, but have nonhydrolyzable mono protonated thiophosphonate salts; chromatography or distillations not required | UTAH STATE UNIVERSITY (US) | 2005-09-13 | — | — | US | claimed |
| US-20050049431-A1 | Thiophosphonate inhibitors of phosphatase enzymes and metallophosphatases | UTAH STATE UNIVERSITY | 2005-03-03 | — | — | US | claimed |
| EP-1487796-A1 | SUBSTITUTED BIARYL AMIDES AS C5A RECEPTOR MODULATORS | NEUROGEN CORPORATION (US) | 2004-12-22 | — | — | EP | claimed |
| US-20040048913-A1 | Substituted biaryl amides as C5a receptor modulators | NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) | 2004-03-11 | — | — | US | claimed |
| WO-2003082826-A1 | SUBSTITUTED BIARYL AMIDES AS C5A RECEPTOR MODULATORS | NEUROGEN CORPORATION (US) | 2003-10-09 | — | — | WO | claimed |
| EP-0678777-B1 | Base film for photographic film | TEIJIN LTD (JP) | 2000-06-21 | — | — | EP | claimed |
| US-4252545-A | COOLING | CHEMISCHE WERKE HULS AG (DE) | 1981-02-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040048913-A1 | Substituted biaryl amides as C5a receptor modulators | C5AR1, C5AR2, C3AR1 | HPGD 2688/4885ALDH1A1 1494/4885CYP1A2 996/4885 |
| US-20050049431-A1 | Thiophosphonate inhibitors of phosphatase enzymes and metallophosphatases | PPME1, MTMR1, PTPRE | HPGD 918/4885ALDH1A1 1993/4885CYP1A2 1439/4885 |
| US-20060178414-A1 | Substituted biaryl amides as C5a receptor modulators | C5AR1, C5AR2, C3AR1 | HPGD 2658/4885ALDH1A1 1680/4885CYP1A2 975/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.